Janssen Sciences Ireland Uc
Clinical trials sponsored by Janssen Sciences Ireland Uc, explained in plain language.
-
HIV kids get lifeline: Long-Term drug access study launches
Disease control OngoingThis study offers children with HIV-1 who previously benefited from the drug rilpivirine continued access to it as part of their treatment. About 48 kids will take the drug along with other HIV medications to keep the virus under control. The main goal is to check the long-term s…
Phase: PHASE2 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
HIV patients get continued access to key drug in safety study
Disease control OngoingThis study gives HIV-1 patients ongoing access to the drug etravirine until they can switch to a local treatment option. It includes 180 participants aged 2 and older who previously benefited from etravirine in a parent trial. The main goal is to monitor safety by tracking any si…
Phase: PHASE3 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated May 06, 2026 16:03 UTC